關於瑞健集團(SHL)
瑞商瑞健集團(SHL)成立於1989年,秉持西方管理模式,致力於在亞洲打造符合國際標準的生產與研發中心。經過多年發展,SHL已成為全球製藥與生物科技領域領先的藥物輸送系統OEM/ODM製造商,產品涵蓋自動安全注射器等創新醫療器材。
除了核心藥物輸送系統,SHL持續擴展產品線,包括軟性醫療產品、醫療氣墊床、醫療床、腦神經手術器具,以及工業設備與醫療用吊昇設備,服務北美、歐洲及亞洲市場,滿足多元化醫療需求。憑藉卓越的企業文化與員工關懷,瑞健醫療榮獲 HR Asia「亞洲最佳企業雇主獎」,並在 「多元、平等與包容(DEI)獎」 類別中獲得特別肯定。
About SHL Group
Founded in 1989, SHL Group is committed to applying Western management principles to establish internationally-standardized production and R&D centers in Asia. Over the years, SHL has become a global leader in OEM/ODM manufacturing of drug delivery systems, including innovative products such as auto-disable safety injectors.
Beyond core drug delivery systems, SHL has expanded its product portfolio to include soft medical products, medical air mattresses, hospital beds, neurosurgical instruments, industrial equipment, and medical lifting devices, serving markets in North America, Europe, and Asia to meet diverse healthcare needs.
Recognized for its outstanding corporate culture and employee care, SHL has been awarded HR Asia’s “Best Companies to Work for in Asia”, with special recognition in the Diversity, Equity & Inclusion (DEI) category.